Literature DB >> 3125112

Kinetics of proteolysis of hog gastric mucin by human neutrophil elastase and by Pseudomonas aeruginosa elastase.

L Poncz1, N Jentoft, M C Ho, D G Dearborn.   

Abstract

Human neutrophil and Pseudomonas aeruginosa elastases were compared for their ability to degrade hog gastric mucin, which was used as a model substrate. P. aeruginosa elastase was more active than neutrophil elastase, and 2 to 10 peptide bonds were hydrolyzed within 5 min. The results demonstrate that both elastases degrade mucins actively at concentrations comparable to physiological levels of neutrophil elastase, which raises the possibility that proteolysis of mucins may be one mechanism of damage during chronic infection and inflammation of the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125112      PMCID: PMC259349          DOI: 10.1128/iai.56.3.703-704.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Tracheobronchial mucus secretion in vivo and in vitro by epithelial tissues from cystic fibrosis and control subjects.

Authors:  T F Boat; P W Cheng; R E Wood
Journal:  Mod Probl Paediatr       Date:  1976 Oct 24-27

2.  The action of proteolytic enzymes on the glycoprotein from pig gastric mucus.

Authors:  M Scawen; A Allen
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

3.  Conformation of mucous glycoproteins in aqueous solvents.

Authors:  R L Shogren; A M Jamieson; J Blackwell; N Jentoft
Journal:  Biopolymers       Date:  1986-08       Impact factor: 2.505

4.  A rapid procedure for the large scale purification of elastase and cathepsin G from human sputum.

Authors:  R R Martodam; R J Baugh; D Y Twumasi; I E Liener
Journal:  Prep Biochem       Date:  1979

5.  Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection.

Authors:  R A Stockley; D Burnett
Journal:  Bull Eur Physiopathol Respir       Date:  1980

6.  Protein labeling by reductive alkylation.

Authors:  N Jentoft; D G Dearborn
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.

Authors:  J D Klinger; D C Straus; C B Hilton; J A Bass
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

8.  Sputum sol-phase proteins and elastase activity in patients with cystic fibrosis.

Authors:  A H Jackson; S L Hill; S C Afford; R A Stockley
Journal:  Eur J Respir Dis       Date:  1984-02

9.  The resistance to tryptic hydrolysis of peptide bonds adjacent to N epsilon,N-dimethyllysyl residues.

Authors:  L Poncz; D G Dearborn
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

10.  Studies on gastric mucoproteins. The production of radioactive mucoproteins by pig gastric mucosal scrapings in vitro.

Authors:  D Snary; A Allen
Journal:  Biochem J       Date:  1972-04       Impact factor: 3.857

View more
  9 in total

1.  SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice.

Authors:  Fabienne Gally; Y Peter Di; Sean K Smith; Maisha N Minor; Yang Liu; Donna L Bratton; S Courtney Frasch; Nicole M Michels; Stephanie R Case; Hong Wei Chu
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Changes in bacterial composition and enzymatic activity in ileostomy and ileal reservoir during intermittent occlusion: a study using dogs.

Authors:  J G Ruseler-van Embden; W R Schouten; L M van Lieshout; H J Auwerda
Journal:  Appl Environ Microbiol       Date:  1992-01       Impact factor: 4.792

3.  In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens.

Authors:  Stephane Desgranges; Florie Le Prieult; Alan Daly; Jennifer Lydon; Marian Brennan; Dilip K Rai; Anusha P Subasinghage; Chandralal M Hewage; Sally-Ann Cryan; Catherine Greene; Noel G McElvaney; Timothy P Smyth; Deirdre Fitzgerald-Hughes; Hilary Humphreys; Marc Devocelle
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

4.  Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis.

Authors:  J W Nelson; M W Tredgett; J K Sheehan; D J Thornton; D Notman; J R Govan
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Growth in and breakdown of purified rabbit small intestinal mucin by Yersinia enterocolitica.

Authors:  M Mantle; C Rombough
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  Mucin degradation mechanisms by distinct Pseudomonas aeruginosa isolates in vitro.

Authors:  Lina Panayiota Aristoteli; Mark D P Willcox
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

7.  Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma.

Authors:  Anh L Innes; Stephen D Carrington; David J Thornton; Sara Kirkham; Karine Rousseau; Ryan H Dougherty; Wilfred W Raymond; George H Caughey; Susan J Muller; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-07       Impact factor: 21.405

8.  Interaction between secretory leucocyte proteinase inhibitor and bronchial mucins or glycopeptides. Physiopathological implications for the protection of mucins against proteolysis by human leucocyte elastase.

Authors:  I Van-Seuningen; J P Aubert; M Davril
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

9.  Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.

Authors:  R Ramphal; N Houdret; L Koo; G Lamblin; P Roussel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.